Similar gMDSC depletion and CTLA-4 blockade did not result in tumor control in non-T-cell inflamed MOC2 tumors, suggesting that rescuing or enhancing TIL function alone is likely not enough to induce anti-tumor immunity in TMEs that do not intrinsically support some degree of anti-tumor immunity at baseline. This evidence concerns the gene CTLA4 and neoplasm.